Atsar F, Bourger H, Baker C
Analyst. 2025; 150(4):620-629.
PMID: 39831313
PMC: 11744447.
DOI: 10.1039/d4an01208a.
Giordani S, Marassi V, Placci A, Zattoni A, Roda B, Reschiglian P
Molecules. 2023; 28(17).
PMID: 37687030
PMC: 10488451.
DOI: 10.3390/molecules28176201.
Marassi V, Macis M, Giordani S, Ferrazzano L, Tolomelli A, Roda B
Molecules. 2022; 27(17).
PMID: 36080254
PMC: 9457993.
DOI: 10.3390/molecules27175485.
Bou-Assaf G, Budyak I, Brenowitz M, Day E, Hayes D, Hill J
J Pharm Sci. 2022; 111(7):2121-2133.
PMID: 34986360
PMC: 9232890.
DOI: 10.1016/j.xphs.2021.12.023.
Gimpel A, Katsikis G, Sha S, Maloney A, Hong M, Nguyen T
Mol Ther Methods Clin Dev. 2021; 20:740-754.
PMID: 33738328
PMC: 7940698.
DOI: 10.1016/j.omtm.2021.02.010.
Electron microscopy-based semi-automated characterization of aggregation in monoclonal antibody products.
Kumar M, Pant A, Bansal R, Pandey A, Gomes J, Khare K
Comput Struct Biotechnol J. 2020; 18:1458-1465.
PMID: 32637043
PMC: 7327430.
DOI: 10.1016/j.csbj.2020.06.009.
Characterization and Control of Dynamic Rearrangement in a Self-Assembled Antibody Carrier.
Dhankher A, Hernandez M, Howard H, Champion J
Biomacromolecules. 2020; 21(4):1407-1416.
PMID: 32134251
PMC: 7450519.
DOI: 10.1021/acs.biomac.9b01712.
Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics.
Bansal R, Gupta S, Rathore A
Pharm Res. 2019; 36(11):152.
PMID: 31463609
DOI: 10.1007/s11095-019-2690-8.
Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®.
Xu Y, Xie L, Zhang E, Gao W, Wang L, Cao Y
MAbs. 2019; 11(3):606-620.
PMID: 30794092
PMC: 6512903.
DOI: 10.1080/19420862.2019.1578147.
Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.
Javeri I, Nellaiappan K, McNemar C, Yakovlevsky K, Soukrati A, Velisetty P
Pharm Res. 2018; 35(9):168.
PMID: 29946984
DOI: 10.1007/s11095-018-2446-x.
Proteins and antibodies in serum, plasma, and whole blood-size characterization using asymmetrical flow field-flow fractionation (AF4).
Leeman M, Choi J, Hansson S, Storm M, Nilsson L
Anal Bioanal Chem. 2018; 410(20):4867-4873.
PMID: 29808297
PMC: 6061777.
DOI: 10.1007/s00216-018-1127-2.
Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.
Barnett G, Perhacs J, Das T, Kar S
Pharm Res. 2018; 35(3):58.
PMID: 29423663
DOI: 10.1007/s11095-017-2306-0.
Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies.
Uchiyama S, Noda M, Krayukhina E
Biophys Rev. 2017; 10(2):259-269.
PMID: 29243091
PMC: 5899733.
DOI: 10.1007/s12551-017-0374-3.
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.
Pisupati K, Benet A, Tian Y, Okbazghi S, Kang J, Ford M
MAbs. 2017; 9(7):1197-1209.
PMID: 28787231
PMC: 5627586.
DOI: 10.1080/19420862.2017.1347741.
Visual Detection of Denatured Glutathione Peptides: A Facile Method to Visibly Detect Heat Stressed Biomolecules.
Farrell M, Reaume R, Pradhan A
Sci Rep. 2017; 7(1):2604.
PMID: 28572597
PMC: 5453926.
DOI: 10.1038/s41598-017-02899-3.
Toward a molecular understanding of nanoparticle-protein interactions.
Treuel L, Nienhaus G
Biophys Rev. 2017; 4(2):137-147.
PMID: 28510093
PMC: 5418382.
DOI: 10.1007/s12551-012-0072-0.
Quantifying Trace Amounts of Aggregates in Biopharmaceuticals Using Analytical Ultracentrifugation Sedimentation Velocity: Bayesian Analyses and F Statistics.
Wafer L, Kloczewiak M, Luo Y
AAPS J. 2016; 18(4):849-60.
PMID: 27184576
DOI: 10.1208/s12248-016-9925-y.
Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe.
Rios Quiroz A, Lamerz J, Da Cunha T, Boillon A, Adler M, Finkler C
Pharm Res. 2015; 33(2):450-61.
PMID: 26474763
DOI: 10.1007/s11095-015-1801-4.
Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.
Fukuda M, Moriyama C, Yamazaki T, Imaeda Y, Koga A
Pharm Res. 2015; 32(12):3803-12.
PMID: 26078002
DOI: 10.1007/s11095-015-1739-6.
Protein corona - from molecular adsorption to physiological complexity.
Treuel L, Docter D, Maskos M, Stauber R
Beilstein J Nanotechnol. 2015; 6:857-73.
PMID: 25977856
PMC: 4419682.
DOI: 10.3762/bjnano.6.88.
